Dr. Cercek on the Impact of Tumor Sidedness on Frontline Treatment in mCRC
February 19th 2020
Andrea Cercek, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the impact of tumor sidedness on frontline treatment decisions in metastatic colorectal cancer (mCRC).